Clinical characteristics | Number (n) | % |
---|---|---|
Total number | 71 | 100 |
Age (years) | Â | Â |
  Median | 59 |  |
  Range | 29 - 75 |  |
Gender | Â | Â |
  Male | 48 | 68 |
  Female | 23 | 32 |
Disease stage | Â | Â |
  IIIA | 66 | 93 |
  IIIB | 5 | 7 |
Tumor classification | Â | Â |
  T1 | 7 | 10 |
  T2 | 43 | 60 |
  T3 | 16 | 23 |
  T4 | 5 | 7 |
Lymph node status | Â | Â |
  N2 | 71 | 100 |
Tumor location | Â | Â |
  Right upper lobe | 28 | 39 |
  Right middle lobe/central | 5 | 7 |
  Right lower lobe | 9 | 13 |
  Left upper lobe | 16 | 23 |
  Left lower lobe | 13 | 18 |
Tumor histology | Â | Â |
  Squamous cell | 25 | 35 |
  Adenocarcinoma | 41 | 58 |
  Large cell | 3 | 4 |
  Other | 2 | 3 |
Surgery type | Â | Â |
  Lobectomy | 44 | 62 |
  Bi-lobectomy | 7 | 10 |
  Pneumonectomy | 20 | 28 |
Resection status | Â | Â |
  R0 | 53 | 75 |
  R1 | 18 | 25 |
Resected lymph nodes | Â | Â |
  Median | 33 |  |
  Range | 10 – 60 |  |
Chemotherapy | Â | Â |
  Induction | 23 | 32 |
  Adjuvant | 48 | 68 |
RT dose (Gy) | Â | Â |
  Median | 50 |  |
  Range | 40 - 60 |  |